CoChat

Computational neurobiology is a useful tool in translational neurology: the example of ataxia

Open access
Brown, Sherry-Ann, McCullough, Louise D., Loew, Leslie M. · 2015 · Frontiers in Neuroscience
Cited by 74

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Hereditary ataxia, or motor incoordination, affects approximately 150,000 Americans and hundreds of thousands of individuals worldwide with onset from as early as mid-childhood. Affected individuals exhibit dysarthria, dysmetria, action tremor, and diadochokinesia. In this review, we consider an array of computational studies derived from experimental observations relevant to human neuropathology. A survey of related studies illustrates the impact of integrating clinical evidence with data from mouse models and computational simulations. Results from these studies may help explain findings in mice, and after extensive laboratory study, may ultimately be translated to ataxic individuals. This inquiry lays a foundation for using computation to understand neurobiochemical and electrophysiological pathophysiology of spinocerebellar ataxias and may contribute to development of therapeutics. The interdisciplinary analysis suggests that computational neurobiology can be an important tool for translational neurology.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnins.2015.00001

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 110

  1. Aiba, 1994, Deficient cerebellar long-term depression and impaired motor learning in mGluR1 mutant mice, Cell, 79, 377, 10.1016/0092-8674(94)90205-4 · DOI · Paper page
  2. Alonso, 2005, A novel H101Q mutation causes PKCgamma loss in spinocerebellar ataxia type 14, J. Hum. Genet, 50, 523, 10.1007/s10038-005-0287-z · doi:10.1007/s10038-005-0287-z
  3. Alviña, 2010, KCa channels as therapeutic targets in episodic ataxia Type-2, J. Neurosci, 30, 7249, 10.1523/JNEUROSCI.6341-09.2010 · DOI
  4. Becker, 2009, A point mutation in TRPC3 causes abnormal Purkinje cell development and cerebellar ataxia in moonwalker mice, Proc. Natl. Acad. Sci. U.S.A, 106, 6706, 10.1073/pnas.0810599106 · DOI · Paper page
  5. Bezprozvanny, 2007, Inositol 1,4,5-tripshosphate receptor, calcium signalling and Huntington's disease, Subcell. Biochem, 45, 323, 10.1007/978-1-4020-6191-2_11 · DOI
  6. Bezprozvanny, 2011, Role of inositol 1,4,5-trishosphate receptors in pathogenesis of Huntington's disease and spinocerebellar ataxias, Neurochem. Res, 36, 1186, 10.1007/s11064-010-0393-y · DOI · Paper page
  7. Bezprozvanny, 2004, Deranged neuronal calcium signaling and Huntington disease, Biochem. Biophys. Res. Commun, 322, 1310, 10.1016/j.bbrc.2004.08.035 · DOI · Paper page
  8. Brown, 2012, Spatial organization and diffusion in neuronal signaling, 133, 10.1007/978-94-007-3858-4_5 · DOI
  9. Brown, 2012, Computational analysis of calcium signaling and membrane electrophysiology in cerebellar Purkinje neurons associated with ataxia, BMC Syst. Biol, 6, 70, 10.1186/1752-0509-6-70 · DOI
  10. Brown, 2015, Inositol 1,4,5-trisphosphate receptor 1 is essential to spinocerebellar ataxia modeling, Front. Neurosci, 8, 10.3389/fnins.2014.00453 · DOI
  11. Brown, 2011, Virtual NEURON: a strategy for merged biochemical and electrophysiological modeling, J. Comput. Neurosci, 31, 385, 10.1007/s10827-011-0317-0 · DOI
  12. Brown, 2008, Analysis of phosphatidylinositol-4,5-bisphosphate signaling in cerebellar Purkinje spines, Biophys. J, 95, 1795, 10.1529/biophysj.108.130195 · DOI
  13. Bürk, 2014, A novel missense mutation in CACNA1A evaluated by in silico protein modeling is associated with non-episodic spinocerebellar ataxia with slow progression, Eur. J. Med. Genet, 57, 207, 10.1016/j.ejmg.2014.01.005 · DOI
  14. Burright, 1995, SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat, Cell, 82, 937, 10.1016/0092-8674(95)90273-2 · DOI · Paper page
  15. Caroli, 2013, Validation of a patient-specific hemodynamic computational model for surgical planning of vascular access in hemodialysis patients, Kidney Int, 84, 1237, 10.1038/ki.2013.188 · doi:10.1038/ki.2013.188
  16. Chen, 2012, Down-regulation of Homer1b/c attenuates glutamate-mediated excitotoxicity through endoplasmic reticulum and mitochondria pathways in rat cortical neurons, Free Radic. Biol. Med, 52, 208, 10.1016/j.freeradbiomed.2011.10.451 · DOI
  17. Chen, 2008, Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 3, J. Neurosci, 28, 12713, 10.1523/JNEUROSCI.3909-08.2008 · DOI · Paper page
  18. Chou, 2008, Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation, Neurobiol. Dis, 31, 89, 10.1016/j.nbd.2008.03.011 · DOI · Paper page
  19. Colomer Gould, 2012, Mouse models of spinocerebellar ataxia type 3 (Machado-Joseph disease), Neurotherapeutics, 9, 285, 10.1007/s13311-012-0117-x · DOI
  20. Cowan, 2012, Spatial modeling of cell signaling networks, Methods Cell Biol, 110, 195, 10.1016/B978-0-12-388403-9.00008-4 · DOI · Paper page
  21. Datta, 2011, Genome wide gene expression regulation by HIP1 Protein Interactor, HIPPI: prediction and validation, BMC Genomics, 12, 463, 10.1186/1471-2164-12-463 · DOI
  22. David, 1997, Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion, Nat. Genet, 17, 65, 10.1038/ng0997-65 · DOI · Paper page
  23. Desaiah, 1991, Inositol 1,4,5-trisphosphate receptors and protein kinase C in olivopontocerebellar atrophy, Brain Res, 552, 36, 10.1016/0006-8993(91)90656-G · doi:10.1016/0006-8993(91)90656-g
  24. De Schutter, 2008, Why are computational neuroscience and systems biology so separate?, PLoS Comput. Biol, 4, e1000078, 10.1371/journal.pcbi.1000078 · DOI · Paper page
  25. De Schutter, 1994a, An active membrane model of the cerebellar Purkinje cell II. Simulation of synaptic responses, J. Neurophysiol, 71, 401, 10.1152/jn.1994.71.1.401 · DOI · Paper page
  26. De Schutter, 1994b, An active membrane model of the cerebellar Purkinje cell. I. Simulation of current clamps in slice, J. Neurophysiol, 71, 375, 10.1152/jn.1994.71.1.375 · DOI · Paper page
  27. Di Gregorio, 2010, Two Italian families with ITPR1 gene deletion presenting a broader phenotype of SCA15, Cerebellum, 9, 115, 10.1007/s12311-009-0154-0 · DOI
  28. Doi, 2003, [Simulation of IP3/Ca2+ signaling pathway in neurons: the system of coincidence detection of input timing in cerebellar Purkinje cells], Tanpakushitsu Kakusan Koso, 48, 817
  29. Dong, 2013, Chinese patients with Huntington's disease initially presenting with spinocerebellar ataxia, Clin. Genet, 83, 380, 10.1111/j.1399-0004.2012.01927.x · DOI
  30. El-Kareh, 2000, A mathematical model for comparison of bolus injection, continuous infusion, and liposomal delivery of doxorubicin to tumor cells, Neoplasia, 2, 325, 10.1038/sj.neo.7900096 · DOI · Paper page
  31. El-Kareh, 2005, Two-mechanism peak concentration model for cellular pharmacodynamics of Doxorubicin, Neoplasia, 7, 705, 10.1593/neo.05118 · doi:10.1593/neo.05118
  32. Euler, 2012, Gene expression analysis on a single cell level in Purkinje cells of Huntington's disease transgenic mice, Neurosci. Lett, 517, 7, 10.1016/j.neulet.2012.03.080 · DOI
  33. Evans, 2009, A mathematical model of doxorubicin penetration through multicellular layers, J. Theor. Biol, 257, 598, 10.1016/j.jtbi.2008.11.031 · DOI
  34. Fillinger, 2002, In vivo analysis of mechanical wall stress and abdominal aortic aneurysm rupture risk, J. Vasc. Surg, 36, 589, 10.1067/mva.2002.125478 · doi:10.1067/mva.2002.125478
  35. Gispert, 1993, Chromosomal assignment of the second locus for autosomal dominant cerebellar ataxia (SCA2) to chromosome 12q23-24.1, Nat. Genet, 4, 295, 10.1038/ng0793-295 · DOI · Paper page
  36. Goetz, 2003, Textbook of Clinical Neurology
  37. Guida, 2001, Complete loss of P/Q calcium channel activity caused by a CACNA1A missense mutation carried by patients with episodic ataxia type 2, Am. J. Hum. Genet, 68, 759, 10.1086/318804 · DOI · Paper page
  38. Guimarães, 2013, What counts as effective genetic counselling for presymptomatic testing in late-onset disorders? A study of the consultand's perspective, J. Genet. Couns, 22, 437, 10.1007/s10897-012-9561-3 · DOI
  39. Hansen, 2013, Changes in Purkinje cell firing and gene expression precede behavioral pathology in a mouse model of SCA2, Hum. Mol. Genet, 22, 271, 10.1093/hmg/dds427 · DOI · Paper page
  40. Hara, 2008, Total deletion and a missense mutation of ITPR1 in Japanese SCA15 families, Neurology, 71, 547, 10.1212/01.wnl.0000311277.71046.a0 · DOI
  41. Hernjak, 2005, Modeling and analysis of calcium signaling events leading to long-term depression in cerebellar Purkinje cells, Biophys. J, 89, 3790, 10.1529/biophysj.105.065771 · DOI
  42. Hines, 1997, The NEURON simulation environment, Neural Comput, 9, 1179, 10.1162/neco.1997.9.6.1179 · DOI · Paper page
  43. Hines, 2001, NEURON: a tool for neuroscientists, Neuroscientist, 7, 123, 10.1177/107385840100700207 · DOI · Paper page
  44. Hourez, 2011, Aminopyridines correct early dysfunction and delay neurodegeneration in a mouse model of spinocerebellar ataxia type 1, J. Neurosci, 31, 11795, 10.1523/JNEUROSCI.0905-11.2011 · DOI
  45. Huang, 2012, Missense mutations in ITPR1 cause autosomal dominant congenital nonprogressive spinocerebellar ataxia, Orphanet J. Rare Dis, 7, 67, 10.1186/1750-1172-7-67 · DOI · Paper page
  46. Huynh, 2000, Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human, Nat. Genet, 26, 44, 10.1038/79162 · DOI · Paper page
  47. Imbrici, 2003, Functional characterization of an episodic ataxia type-1 mutation occurring in the S1 segment of hKv1.1 channels, Pflugers Arch, 446, 373, 10.1007/s00424-002-0962-2 · doi:10.1007/s00424-002-0962-2
  48. Inoue, 2001, Calcium dynamics and electrophysiological properties of cerebellar Purkinje cells in SCA1 transgenic mice, J. Neurophysiol, 85, 1750, 10.1152/jn.2001.85.4.1750 · DOI
  49. Iwaki, 2008, Heterozygous deletion of ITPR1, but not SUMF1, in spinocerebellar ataxia type 16, J. Med. Genet, 45, 32, 10.1136/jmg.2007.053942 · DOI
  50. Jacobi, 2012, Spinocerebellar ataxia types 1, 2, 3 and 6: the clinical spectrum of ataxia and morphometric brainstem and cerebellar findings, Cerebellum, 11, 155, 10.1007/s12311-011-0292-z · DOI
  51. Ji, 2014, Increased protein kinase C gamma activity induces Purkinje cell pathology in a mouse model of spinocerebellar ataxia 14, Neurobiol. Dis, 70C, 1, 10.1016/j.nbd.2014.06.002 · DOI
  52. Kandel, 2000, ‘The Cerebellum,’ Principles of Neuroscience
  53. Kasumu, 2012, Deranged calcium signaling in purkinje cells and pathogenesis in spinocerebellar Ataxia 2 (SCA2) and other Ataxias, Cerebellum, 11, 630, 10.1007/s12311-010-0182-9 · DOI · Paper page
  54. Kasumu, 2012a, Selective positive modulator of calcium-activated potassium channels exerts beneficial effects in a mouse model of spinocerebellar ataxia type 2, Chem. Biol, 19, 1340, 10.1016/j.chembiol.2012.07.013 · DOI
  55. Kasumu, 2012b, Chronic suppression of inositol 1,4,5-triphosphate receptor-mediated calcium signaling in cerebellar purkinje cells alleviates pathological phenotype in spinocerebellar ataxia 2 mice, J. Neurosci, 32, 12786, 10.1523/JNEUROSCI.1643-12.2012 · DOI
  56. Kawaguchi, 1994, CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1, Nat. Genet, 8, 221, 10.1038/ng1194-221 · DOI · Paper page
  57. Kelp, 2013, A novel transgenic rat model for spinocerebellar ataxia type 17 recapitulates neuropathological changes and supplies in vivo imaging biomarkers, J. Neurosci, 33, 9068, 10.1523/JNEUROSCI.5622-12.2013 · DOI
  58. Koide, 1994, Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA), Nat. Genet, 6, 9, 10.1038/ng0194-9 · DOI · Paper page
  59. Koide, 1999, A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease?, Hum. Mol. Genet, 8, 2047, 10.1093/hmg/8.11.2047 · DOI · Paper page
  60. Liu, 2009, Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 2, J. Neurosci, 29, 9148, 10.1523/JNEUROSCI.0660-09.2009 · DOI · Paper page
  61. Matilla-Dueñas, 2014, Consensus paper: pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias, Cerebellum, 13, 269, 10.1007/s12311-013-0539-y · DOI
  62. Miyasho, 2001, Low-threshold potassium channels and a low-threshold calcium channel regulate Ca2+ spike firing in the dendrites of cerebellar Purkinje neurons: a modeling study, Brain Res, 891, 106, 10.1016/S0006-8993(00)03206-6 · DOI
  63. Musova, 2013, Spinocerebellar ataxias type 8, 12, and 17 and dentatorubro-pallidoluysian atrophy in Czech ataxic patients, Cerebellum, 12, 155, 10.1007/s12311-012-0403-5 · DOI
  64. Nakamura, 2001, SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein, Hum. Mol. Genet, 10, 1441, 10.1093/hmg/10.14.1441 · DOI · Paper page
  65. Novak, 2010a, PAW32 ITPR1 gene deletion causes spinocerebellar ataxia 15/16: a genetic, clinical and radiological description of a novel kindred, J. Neurol. Neurosurg. Psychiatr, 81, e32, 10.1136/jnnp.2010.226340.60 · doi:10.1136/jnnp.2010.226340.60
  66. Novak, 2010b, An ITPR1 gene deletion causes spinocerebellar ataxia 15/16: a genetic, clinical and radiological description, Mov. Disord, 25, 2176, 10.1002/mds.23223 · DOI
  67. Ogasawara, 2008, Systems biology perspectives on cerebellar long-term depression, Neurosignals, 16, 300, 10.1159/000123040 · DOI
  68. Ogura, 2001, Motor discoordination in mutant mice heterozygous for the type 1 inositol 1,4,5-trisphosphate receptor, Behav. Brain Res, 122, 215, 10.1016/S0166-4328(01)00187-5 · DOI
  69. Orr, 2012, Cell biology of spinocerebellar ataxia, J. Cell Biol, 197, 167, 10.1083/jcb.201105092 · DOI · Paper page
  70. Pulst, 1996, Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2, Nat. Genet, 14, 269, 10.1038/ng1196-269 · DOI · Paper page
  71. Raut, 2013, The role of geometric and biomechanical factors in abdominal aortic aneurysm rupture risk assessment, Ann. Biomed. Eng, 41, 1459, 10.1007/s10439-013-0786-6 · DOI
  72. Reich, 1979, Mathematical model for adriamycin (doxorubicin) pharmacokinetics, Cancer Chemother. Pharmacol, 3, 125, 10.1007/BF00254984 · doi:10.1007/bf00254984
  73. Rodríguez-Quiroga, 2013, Huntington's disease masquerading as spinocerebellar ataxia, BMJ Case Rep, 2013, bcr2012008380, 10.1136/bcr-2012-008380 · doi:10.1136/bcr-2012-008380
  74. SandonÃ, 2003, Subcellular distribution of Homer 1b/c in relation to endoplasmic reticulum and plasma membrane proteins in Purkinje neurons, Neurochem. Res, 28, 1151, 10.1023/A:1024264025401 · DOI
  75. Sarkisov, 2008, Order-dependent coincidence detection in cerebellar Purkinje neurons at the inositol trisphosphate receptor, J. Neurosci, 28, 133, 10.1523/JNEUROSCI.1729-07.2008 · DOI
  76. Sausbier, 2004, Cerebellar ataxia and Purkinje cell dysfunction caused by Ca2+-activated K+ channel deficiency, Proc. Natl. Acad. Sci. U.S.A, 101, 9474, 10.1073/pnas.0401702101 · DOI · Paper page
  77. Schaff, 2000, Physiological modeling with virtual cell framework, Meth. Enzymol, 321, 1, 10.1016/S0076-6879(00)21184-1 · DOI
  78. Schöls, 2004, Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis, Lancet Neurol, 3, 291, 10.1016/S1474-4422(04)00737-9 · DOI · Paper page
  79. Schuler-Faccini, 2014, Genetic counseling and presymptomatic testing programs for Machado-Joseph Disease: lessons from Brazil and Portugal, Genet. Mol. Biol, 37, 263, 10.1590/S1415-47572014000200012 · doi:10.1590/s1415-47572014000200012
  80. Shakkottai, 2011, Early changes in cerebellar physiology accompany motor dysfunction in the polyglutamine disease spinocerebellar ataxia type 3, J. Neurosci, 31, 13002, 10.1523/JNEUROSCI.2789-11.2011 · DOI · Paper page
  81. Shiraishi, 2004, Differential expression of Homer family proteins in the developing mouse brain, J. Comp. Neurol, 473, 582, 10.1002/cne.20116 · DOI · Paper page
  82. Slepchenko, 2010, Use of virtual cell in studies of cellular dynamics, Int. Rev. Cell Mol. Biol, 283, 1, 10.1016/S1937-6448(10)83001-1 · DOI
  83. Smeets, 2014, Cerebellar ataxia and functional genomics: identifying the routes to cerebellar neurodegeneration, Biochim. Biophys. Acta, 1842, 2030, 10.1016/j.bbadis.2014.04.004 · DOI
  84. Soudah, 2013, CFD modelling of abdominal aortic aneurysm on hemodynamic loads using a realistic geometry with CT, Comput. Math. Methods Med, 2013, 472564, 10.1155/2013/472564 · doi:10.1155/2013/472564
  85. Spence, 2012, Computational prediction of the polyQ and CAG repeat spinocerebellar ataxia network based on sequence identity to untranslated regions, Gene, 509, 273, 10.1016/j.gene.2012.07.068 · DOI
  86. Storey, 2001, A new autosomal dominant pure cerebellar ataxia, Neurology, 57, 1913, 10.1212/WNL.57.10.1913 · DOI
  87. Street, 1997, The type 1 inositol 1,4,5-trisphosphate receptor gene is altered in the opisthotonos mouse, J. Neurosci, 17, 635, 10.1523/JNEUROSCI.17-02-00635.1997 · DOI
  88. Suzuki, 2012, DRPLA transgenic mouse substrains carrying single copy of full-length mutant human DRPLA gene with variable sizes of expanded CAG repeats exhibit CAG repeat length- and age-dependent changes in behavioral abnormalities and gene expression profiles, Neurobiol. Dis, 46, 336, 10.1016/j.nbd.2012.01.014 · DOI
  89. Takagishi, 1996, The dilute-lethal (dl) gene attacks a Ca2+ store in the dendritic spine of Purkinje cells in mice, Neurosci. Lett, 215, 169, 10.1016/0304-3940(96)12967-0 · DOI
  90. Tang, 2009, Neuroprotective effects of inositol 1,4,5-trisphosphate receptor C-terminal fragment in a Huntington's disease mouse model, J. Neurosci, 29, 1257, 10.1523/JNEUROSCI.4411-08.2009 · DOI
  91. Tang, 2003a, Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1, Neuron, 39, 227, 10.1016/S0896-6273(03)00366-0 · DOI · Paper page
  92. Tang, 2003b, Modulation of type 1 inositol (1,4,5)-trisphosphate receptor function by protein kinase a and protein phosphatase 1alpha, J. Neurosci, 23, 403, 10.1523/JNEUROSCI.23-02-00403.2003 · DOI
  93. Tonelli, 2006, Early onset, non fluctuating spinocerebellar ataxia and a novel missense mutation in CACNA1A gene, J. Neurol. Sci, 241, 13, 10.1016/j.jns.2005.10.007 · DOI
  94. Trottier, 1994, Instability of CAG repeats in Huntington's disease: relation to parental transmission and age of onset, J. Med. Genet, 31, 377, 10.1136/jmg.31.5.377 · DOI · Paper page
  95. Tu, 2004, Association of type 1 inositol 1,4,5-trisphosphate receptor with AKAP9 (Yotiao) and protein kinase A, J. Biol. Chem, 279, 19375, 10.1074/jbc.M313476200 · DOI · Paper page
  96. Ueda, 2013, A novel mutation in the C2 domain of protein kinase C gamma associated with spinocerebellar ataxia type 14, J. Neurol, 260, 1664, 10.1007/s00415-013-6916-0 · doi:10.1007/s00415-013-6916-0
  97. van de Leemput, 2007, Deletion at ITPR1 underlies ataxia in mice and spinocerebellar ataxia 15 in humans, PLoS Genet, 3, e108, 10.1371/journal.pgen.0030108 · DOI · Paper page
  98. van Gaalen, 2013, A de novo SCA14 mutation in an isolated case of late-onset cerebellar ataxia, Mov. Disord, 28, 1902, 10.1002/mds.25572 · doi:10.1002/mds.25572
  99. Velázquez-Pérez, 2014a, Progression of early features of spinocerebellar ataxia type 2 in individuals at risk: a longitudinal study, Lancet Neurol, 13, 482, 10.1016/S1474-4422(14)70027-4 · DOI
  100. Velázquez-Pérez, 2014b, Comprehensive study of early features in spinocerebellar Ataxia 2: delineating the prodromal stage of the disease, Cerebellum, 13, 568, 10.1007/s12311-014-0574-3 · DOI
  101. Vig, 2001, Calcium homeostasis and spinocerebellar ataxia-1 (SCA-1), Brain Res. Bull, 56, 221, 10.1016/S0361-9230(01)00595-0 · DOI
  102. Wagner, 2003, Myosin V and the endoplasmic reticulum: the connection grows, J. Cell Biol, 163, 1193, 10.1083/jcb.200311077 · DOI
  103. Wang, 2000, Coincidence detection in single dendritic spines mediated by calcium release, Nat. Neurosci, 3, 1266, 10.1038/81792 · DOI · Paper page
  104. Xu, 2003, Kinetic analysis of receptor-activated phosphoinositide turnover, J. Cell Biol, 161, 779, 10.1083/jcb.200301070 · DOI · Paper page
  105. Yue, 1997, Progressive ataxia due to a missense mutation in a calcium-channel gene, Am. J. Hum. Genet, 61, 1078, 10.1086/301613 · DOI · Paper page
  106. Zecevic, 1999, Calcium signaling molecules in human cerebellum at midgestation and in ataxia, Early Hum. Dev, 54, 103, 10.1016/S0378-3782(98)00090-5 · DOI
  107. Zhan, 2013, A mathematical model for thermosensitive liposomal delivery of Doxorubicin to solid tumour, J. Drug Deliv, 2013, 172529, 10.1155/2013/172529 · DOI · Paper page
  108. Zhang, 2008, Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease, Neurobiol. Dis, 31, 80, 10.1016/j.nbd.2008.03.010 · DOI
  109. Zhuchenko, 1997, Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel, Nat. Genet, 15, 62, 10.1038/ng0197-62 · DOI · Paper page
  110. Zuliani, 2007, Homer 3 autoimmunity in subacute idiopathic cerebellar ataxia, Neurology, 68, 239, 10.1212/01.wnl.0000251308.79366.f9 · DOI

Cited by

See all 74

Metadata

Authors
Brown, S.-A., McCullough, L. D., & Loew, L. M.
Venue
Frontiers in Neuroscience
Published
2015-01-21
Volume
9
Pages
1-1
ISSN
1662-453X (ISSN-L)
OpenAlex
W2010170814
Cited by
74
References
10
FWCI
6.05
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.